Clinical Trials on Breast Cancer Metastatic Breast Cancer in Switzerland
Total 887 results
-
University of ZurichUnknownBreast Cancer | Metastatic Neoplasm | ERBB2Switzerland
-
Prof. Wolfgang JanniEli Lilly and CompanyRecruitingHormone Receptor-positive Metastatic Breast Cancer | HER2-negative Metastatic Breast CancerGermany, Switzerland
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
BayerCompletedMetastatic Breast CancerSpain, Austria, United Kingdom, France, Finland, Poland, Germany, Sweden, Italy, Switzerland
-
Swiss Group for Clinical Cancer ResearchTerminatedBreast Cancer | Metastatic Breast AdenocarcinomaSwitzerland
-
Breast International GroupJules Bordet Institute; Frontier Science & Technology Research Foundation,...RecruitingMetastatic Breast CancerBelgium, Spain, Portugal, United Kingdom, Italy, Germany, Iceland, Luxembourg, Sweden, Switzerland
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticGermany, Italy, Israel, Poland, Switzerland, United Kingdom, Greece
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
Manuela EicherSwiss Cancer League; Lindenhofgruppe AGCompletedBreast Neoplasm | Self-Management | Intervention | Cancer Survivorship | Early-Stage Breast CancerSwitzerland
-
Vincent Vinh-HungVarian Medical SystemsActive, not recruitingBreast Cancer FemaleSwitzerland
-
Lindenhofgruppe AGUniversity of Bern; StiftungLindenhofTerminatedBreast Cancer FemaleSwitzerland
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
Centre Hospitalier Universitaire VaudoisRecruitingTriple Negative Breast CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingTriple-negative Breast Cancer | TNBC - Triple-Negative Breast CancerSwitzerland
-
Eli Lilly and CompanyAvailableMetastatic Breast CancerAustralia, Canada, Egypt, India, Italy, Korea, Republic of, Malaysia, Singapore, South Africa, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
Swiss Group for Clinical Cancer ResearchCompletedMetastatic Breast CancerFrance, Switzerland, Netherlands, Germany
-
Puma Biotechnology, Inc.CompletedHER2+ Metastatic Breast Cancer (MBC)United States, Canada, Spain, Singapore, Korea, Republic of, Taiwan, United Kingdom, Israel, Australia, Japan, Hong Kong, Finland, Ireland, Italy, France, Portugal, Germany, Sweden, Belgium, Brazil, Czechia, Switzerland, Argentina, Au... and more
-
NantCell, Inc.CompletedBreast Cancer | Metastatic Cancer | Breast TumorsUnited States, France, Canada, United Kingdom, Spain, Australia, Germany, Ireland, Switzerland
-
Centre Hospitalier Universitaire VaudoisTerminatedBreast Cancer | Lung CancerSwitzerland
-
Brust-Zentrum AGCompleted
-
Swiss Federal Institute of TechnologyKantonsspital BadenCompletedBreast CancerSwitzerland
-
University of ZurichTerminated
-
Christian SchweglerRecruitingChemotherapy Effect | Breast Cancer FemaleSwitzerland
-
Aline ReinmannCompletedCancer, Breast | Cancer, GynecologicSwitzerland
-
Palleos Healthcare GmbHmobile Health AGRecruiting
-
Kantonsspital Winterthur KSWTerminatedBreast Cancer, Invasive DuctalSwitzerland
-
Ente Ospedaliero Cantonale, BellinzonaPolitecnico di Milano; Clinical Trial Unit Ente Ospedaliero CantonaleCompleted
-
OnkoZentrum Zürich AGUniversity of Zurich; Palleos Healthcare GmbHCompletedHER2-positive Breast Cancer | Biosimilar | Patient Reported OutcomeSwitzerland
-
Clinica Luganese MoncuccoSwiss National Science Foundation; Curzio Rüegg, MD, Head of Department, University... and other collaboratorsCompletedBreast CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompleted
-
University Hospital, Basel, SwitzerlandCompletedBreast CancerSwitzerland
-
European Organisation for Research and Treatment...CompletedBreast CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompleted
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Active, not recruitingBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationItaly, Spain, United States, Czechia, Romania, France, Korea, Republic of, United Kingdom, Hungary, Japan, Peru, Poland, Russian Federation, Turkey, China, Taiwan, Bulgaria, Switzerland, Mexico
-
University Hospital, Basel, SwitzerlandETH Zurich - The Aceto LabCompletedBreast Cancer | Circulating Tumor Cells (CTCs)Switzerland
-
Centre Hospitalier Universitaire VaudoisUnknown
-
Swiss Group for Clinical Cancer ResearchCompletedBreast CancerSwitzerland
-
West German Study GroupAgendiaCompletedBreast CancerSwitzerland, Austria, Germany
-
Oncology Institute of Southern SwitzerlandRecruiting
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Constanze ElfgenRecruiting
-
Puma Biotechnology, Inc.CompletedAdvanced Breast CancerUnited States, Switzerland, China, France
-
University Hospital, Basel, SwitzerlandSana Kliniken Düsseldorf GmbHRecruitingBreast Cancer | LymphedemaSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompleted
-
University Hospital Inselspital, BerneCompletedBreast CancerSwitzerland
-
Plastic Surgery Group AG by Prof. Jian FarhadiCompletedBreast CancerSwitzerland
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); Breast International GroupTerminatedBreast CancerSwitzerland, Italy, Hungary
-
Novartis PharmaceuticalsRecruiting